El presidente Donald Trump, que parece decidido a anunciar una vacuna para COVID-19 antes de las elecciones, podría autorizarla legalmente a pesar de las objeciones.
President Donald Trump has the legal power to authorize a COVID vaccine over the objections of the Food and Drug Administration and vaccine manufacturers. Such a move could further erode public trust in a vaccine and foist an unsafe shot on Americans.
The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they’ll opt instead to use the scarce resource to complete a clinical trial.
A small allergy clinic in Medford, Oregon, might seem an unlikely place to recruit hundreds of volunteers to test the Moderna vaccine against COVID-19. But its steward has a record of leading hundreds of clinical trials.
“Lost on the Frontline” is an ongoing project by Kaiser Health News and The Guardian that aims to document the lives of health care workers in the U.S. who died from COVID 19, and to investigate why so many are victims of the disease.
People have flooded U.S. testing sites with requests to participate in the pivotal, late-stage clinical trials of the first two COVID-19 vaccine candidates.
Las personas de raza negra y las latinas (que pueden ser de cualquier raza) tienen tres veces más probabilidades de infectarse con el coronavirus que causa COVID-19 que las personas blancas no hispanas
Although racial minorities, older people and those with underlying medical conditions are most at risk from COVID-19, they’ve historically been the least likely to be included in clinical trials for treatments for serious diseases. Will that change with COVID-19?
A 2016 series on the 14th-century plague became must-see TV during spring’s COVID-19 outbreak — and flooded Purdue medievalist Dorsey Armstrong with questions about parallels between that pandemic and the current crisis.
For three years, staffers at UCLA Health have been quietly fulfilling final wishes for dying patients in the intensive care unit. Amid the isolating forces of the pandemic, their work has become all the more meaningful.
Amid questions about the accuracy of the COVID-19 antibody tests flooding the market — and the usefulness of the results they provide — the FDA has belatedly stepped in to try to rein in the chaos.
The pandemic has forced millions of families to weigh the risks of vulnerable grandparents getting too close to their beloved grandchildren — against the heartache of staying away.
A possibility that the blood of people who had COVID could save others has set off a mad scramble for donors — with top-dollar offers and a plan that relies on the blood of 10,000 Orthodox Jewish women.
Public officials are putting high hopes on new blood tests as a means of determining who has developed antibodies to COVID-19, and with those antibodies, presumed immunity. But experts caution the tests are largely unreliable and the science is still catching up.
Funcionarios de la Organización Mundial de la Salud se manifestaron en contra de los planes de algunos países de tener “pasaportes de inmunidad”, que habilitarían a salir y trabajar.
En todo los Estados Unidos, COVID-19 está alterando radicalmente la atención médica, no solo para los adultos mayores vulnerables sino también para las embarazadas y sus recién nacidos.
COVID-19 is changing medical care, not only for vulnerable elders but also for pregnant women and their babies entering the world.
As efforts ramp up to collect blood plasma from the first survivors of COVID-19, families of critically ill patients are jockeying to obtain the still-unproven antibody treatment.
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
New guidelines issued Tuesday could speed a century-old therapy to those critically ill with the pandemic virus.